Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)

SHE:002727 Revenue

Yixintang Pharmaceutical Group had revenue of 4.23B CNY in the quarter ending September 30, 2026, with 3.53% growth. This brings the company's total for the last twelve months to 17.03B, down -2.18% year-over-year. In the year 2025, Yixintang Pharmaceutical Group had annual revenue of 17.34B, down -3.69%. That makes Yixintang Pharmaceutical Group the 4,259th largest company in the world by revenue and 541st in China.

• Revenue (ttm): 17.03B
• Revenue Growth: -2.18%
• P/S Ratio: 0.42
• Revenue / Employee: 488.79K
• Employees: 34,848
• Market Cap: 7.38B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Retail 12.95B 74.7%
• Wholesale 3.78B 21.8%
• Unallocated Other Operating Income 599.91M 3.5%

By Geography

Chart

• South-West 13.45B 77.6%
• South China Region 1.74B 10.0%
• Northern China 936.23M 5.4%
• Unallocated 599.91M 3.5%
• Central China 450.93M 2.6%
• East China 158.96M 0.9%

Fiscal year ended Dec 31, 2025 See the full SHE:002727 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.34B	-664.21M	-3.69%
Dec 31, 2024	18.00B	620.14M	3.57%
Dec 31, 2023	17.38B	-51.30M	-0.29%
Jan 1, 2023	17.43B	2.84B	19.50%
Jan 1, 2022	14.59B	1.93B	15.26%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error